Direct-to-consumer advertising (DTCA) of pharmaceuticals: An updated review of the literature and debate since 2003

Economic Affairs

Volumn 26, Issue 3, 2006, Pages 24-32

  Auton, Frank ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INDUSTRIAL REGULATION; PHARMACEUTICAL INDUSTRY;

AUSTRALASIA; NEW ZEALAND; NORTH AMERICA; UNITED STATES;

EID: 33747409811     PISSN: 02650665     EISSN: 14680270     Source Type: Journal    
DOI: 10.1111/j.1468-0270.2006.00646.x     Document Type: Review

References (52)

1. Advanced Analytics Inc. (2004) Available at http://www.findsvp.com/about/ 2004/02-03Pharmaceutical.cfm (accessed 3 February 2004).
2. Alliance for Access to Medical Information (AAMI) (2002) How Do Canadians Feel about DTCA?, Ottawa: AAMI.
3. Allison-Ottey, S. (2003) 'DTC and the AA Physician and Patient'. Available at http://www.fda.gov/cder/ddmac/P1AllisonOttey/index.htm (accessed 22 September).
4. Anthony, P. (2005) Available at http://www.phrma.org/actions (accessed 29 September).
5. Auton, F. (2004) 'The Advertising of Pharmaceuticals Direct to Consumers: A Critical Review of the Literature and Debate', International Journal of Advertising, 23, 23-52.
6. Berndt, E. (2002) 'An Analysis of the Diffusion of New Anti-depressants: Variety, Quality, and Marketing Efforts', Journal of Mental Health Policy and Economics, 5, 3-19.
7. Bishop, T. (2005) 'Direct Pitch', Baltimore Sun, 20 March, pp. D1-D2.
8. Brekke, K. and M. Kuhn (2005) 'DTCA in Pharmaceutical Markets', CESifo Working Paper No. 1493. Available at http://www.CESifo.de.
9. Deshpande, A. (2004) 'Direct to Consumer Advertising and its Utility in Healthcare Decision Making: A Consumer Perspective', Journal of Health Communication, 9, 499-513.
10. Donohue, J. and E. Berndt (2004) 'Effects of DTCA on Medication Choice: The Case for Anti-depressants', Journal of Public Policy and Marketing, 23, 115-127.
11. Donohue, J., E. Berndt, M. Rosenthal, A. Epstein, M. Arnold and R. Frank (2004) 'Effects of Pharmaceutical Promotion on Adherence to Treatment Guidelines for Depression', Medical Care, 42, 1176-1185.
12. Edwards, J. (2005) 'PhRMA Unveils New Guidelines'. Available at http://www.mediaweek.com (accessed 2 August).
13. Gascoigne, D. (2004) DTC at the Crossroads: A 'Direct'Hit or Miss?, IMS Management Consulting. Available at http://www.imshealth.com.
14. Gilbody, J. (2005) 'Benefits and Harms of DTCA: A Systematic Review', Quality and Safety in Healthcare, 14, 246-250.
15. Goldman, M. (2005) Direct to Consumer Advertising: Benefit to Patients. Available at http://www.drugandmarket.com/ default.asp?section=feature&article=042205.
16. Hansen, R. and M. Droege (2005) 'Methodological Challenges Surrounding DTCA Research -The Measurement Conundrum', Research in Social and Administrative Pharmacy, 1, 331-347.
17. Hansen, R., N. Shaheen and J. Schommer (2005) 'Factors Influencing the Shift of Patients from One PPI to Another: The Effect of DTCA', Clinical Therapeutics, 27, 9, 1478-1487.
18. Hernstein, M. (2004) 'How Consumers'Attitudes toward DTCA Influence Ad Effectiveness and Consumer and Physician Behaviour', Marketing Letters, 15, 201-212.
19. Hoek, J. and P. Grendall (2003) 'DTCA: A Consumer Survey', Department of Marketing Research Report.
20. Hollon, M. (2005) 'DTCA: A Haphazard Approach to Health Promotion', Journal of American Marketing Association, 293, 2030-2035.
21. Holmer, A. (2002) 'DTCA -Strengthening Our Healthcare System', New England Journal of Medicine, 346, 526-528.
22. Hone, F. and R. Benson (2004) 'DTC European Style', Pharmaceutical Executive. Available at http://www.pharmaexec.com/pharmexec/content/ printContentPopup.jsp?id=87982 (accessed 1 March).
23. Iisuka, T. (2004) 'What Explains the Use of DTCA of Prescription Drugs?', Journal of Industrial Economics, 52, 349-378.
24. Kessler, R. (2003) 'The Epidemiology of Major Depressive Disorder: Results from the National Comorbidity Survey Replication', Journal of the American Medical Association, 289, 3095-3105.
25. Kravitz, R. (2005) 'Influence of Patients'Requests for Direct-to-Consumer Advertised Antidepressants: A Randomized Controlled Trial', Journal of the American Medical Association, 293, 1993-2002.
26. Krusewski, S. (2005) 'The American Medical Association's Response to Pharmaceutical Advertising'. Available at http://www.bmj.bmjjournals.com/ cgi/eletters/331/7507/7-a.
27. Lenzer, J. (2005) 'Professors Speak Out against DTCA', British Medical Journal, 331, 1040.
28. Mandese, J. (2005) 'Special Report: TV Advertising & Pharmaceuticals', Broadcasting and Cable, 16 May, pp. 24-25.
29. Masia, N. (2003) 'Economic Impact of DTCA Advertising'. Available at http://www.fda.gov/cder/ddmac/P4Masia/index.htm (accessed 22 September).
30. Maubach, N. and J. Hoek (2005) 'New Zealand General Practitioners'Views on DTCA: A Qualitative Analysis', New Zealand Medical Journal, 118, 1215, 1-9.
31. McGann, R. (2004) 'Pharmaceuticals Target DTC Marketing in 2005', Healthcare. Available at http://www.clickz.com/stats/sectors/healthcare/ print.php/3451121 (accessed 22 December).
32. McGlynn, E., S. Asch, J. Adams, J. Keesey, J. Hicks, A. DeCristofaro and E. Kerr (2003) 'The Quality of Health Care Delivered to Adults in the United States', New England Journal of Medicine, 348, 2635-2645.
33. Miller, K. and D. Waller (2004) 'Attitudes towards DTCA in Australia: An Exploratory Study', International Journal of Advertising, 23, 389-405.
34. Mintzes, B. (2005) 'Introduction of DTCA in Canada: An Opinion Survey on Regulatory Policy', Research in Social and Administrative Pharmacy, 1, 310-330.
35. Morgan, S., B. Mintzes and M. Barer (2003) 'The Economics of Direct-to-Consumer Advertising of Prescription-only Drugs: Prescribed to Improve Consumer Welfare?', Journal of Health Services Research & Policy, 8, 237-244.
36. Murray, E., B. Lo, L. Pollack, K. Donelan and K. Lee (2004) 'DTCA: Public Perceptions of its Effect on Health Behaviours, Health Care, and the Doctor-Patient Relationship', Journal of American Board of Family Practice, 17, 6-18.
37. OECD (2004) OECD Health Data 2004, 3rd edn., Paris: OECD.
38. Reast, J., D. Palihawadana and G. Spickett-Jones (2004) 'UK Physicians'Attitudes towards DTCA: An Extension and Review', International Journal of Advertising, 23, 229-251.
39. Richardson, L. and V. Luchsinger (2005) 'Direct-to-Customer Advertising of Pharmaceutical Products: Issue Analysis and Direct-to-Consumer Promotion', Journal of Academy of Business, 7, 2, 100-104.
40. Robinson, A. (2004) 'Direct to Consumer Pharmaceutical Advertising', Arch Internal Medicine, 164, 427-432.
41. Rosenthal, M. (2004) 'Comment: The Economics of DTCA: Prescribed to Increase Consumer Welfare?', Journal of Health Service Research Policy, 9, 39-42.
42. Schommer, J. and R. Hansen (2005) 'The Study of DTCA for Prescription Drugs', Research in Social and Administrative Pharmacy, 1, 348-368.
43. Shah, M., J. Bentley, D. McCaffrey and E. Kolassa (2005) 'DTCA and the Patient-Physician Relationship', Research in Social and Administrative Pharmacy, 1, 211-230.
44. Spence, M. (2005) 'DTCA of COX-2 Inhibitors: Effect on Appropriate Prescribing', Medical Care Research and Review, 62, 544-590.
45. Sweet, D. (2005) Available at http://www.acponline.org/college/pressroom/ dtc_ads.htm.
46. Theodore, R. and H. Parmar (2005) 'Pharmaceutical DTCA in Europe', Pharmaceutical Field, 69, 16-17.
47. Toiviainen, H., L. Vuorenkoski and E. Hemminki (2004) 'Finnish Physicians Show Little Support for DTCA', New Zealand Medical Journal, 117, 1195, U907.
48. Toop, L. and D. Richards (2004) 'Physicians'Negative Views of Direct-to-Consumer Advertising (DTCA): The International Evidence Grows', New Zealand Medical Journal, 117, 1195.
49. Toshiaki, L. and J. Ginger Zhe (2005) 'The Effect of Prescription Drug Advertising on Doctors', Journal of Economics and Management Strategy, 14, 701-727.
50. Vatjanapukka, V. (2004) 'Relationship between Consumer Knowledge, Prescription Drug Advertising Exposure and Attitudes towards DTCA', International Journal of Medical Marketing, 4, 350-360.
51. Weissman, J., D. Blumenthal, A. Silk, M. Newman, K. Zapert, R. Leitman and S. Feibelmann (2004) 'Physicians'Report on Patient Encounters Involving Direct to Consumer Advertising', Health Affairs. Available at http://content.healthaffairs.org/cgi/content/full/hlthaff.w4.219v1/DC1.
52. West, D. (2005) 'Media Spend Trends: Changing Lanes', Pharmaceutical Executive. Available at http://www.pharmaexec.com/pharmexec/content/ printContentPopup.jsp?id=162132 (accessed 1 May).